A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Related Research units
Bibliographical data
Original language | German |
---|---|
Article number | 2 |
ISSN | 0360-3016 |
Publication status | Published - 2001 |
pubmed | 11579925 |
---|